BDNF and myeloid sarcoma: The findings imply that the levels of selected neurotrophins (BDNF and NT4/5), heat shock proteins (HSP70 and HSP27), SIRT1, and selected miRNAs in PBMC cells may function as biomarkers of inflammation in the CNS and neurodegenerative processes in MS patients.